| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.04 |